調控JAK激酶的喹唑啉衍生物和其使用方法

• 收藏
• 分享

专利权人:

AMBIT BIOSCIENCES CORPORATION

发明人:

ABRAHAM, SUNNY,CHAO, QI,HADD, MICHAEL, J.,HOLLADAY, MARK, W.,LIU, GANG,SETTI, EDUARDO

申请号：

HK12106108.2

公开号：

HK1165789B

申请日:

2012.06.21

申请国别(地区):

HK

年份:

2014

代理人:

摘要：

Provided herein are quinazoline compounds of formula (I): The compounds are useful for treatment of JAK kinase mediated diseases, including JAK2 kinase-, JAK3 kinase- or TYK2 kinase-mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/